Year: 2021
Type: article
Abstract: Despite its start in the early 2000s, synthetic biology is still overall perceived as a young discipline. In some countries, such as the US, synthetic biology is academically and industrially established, while in others, including Germany, it is still an upcoming field of research. Issues with funding schemes, commercial translation of technologies, public perception, and regulations need to be addressed to establish synthetic biology as a key discipline of the 21st century. This perspective article reviews the German and European synthetic biology landscape and how the German Association for Synthetic Biology (GASB) is addressing the above-mentioned challenges with its events and community-building activities.
Source: Biotechnology Notes
Authors: Nicolas Krink, Anne C. Löchner, Hendrik Cooper, Chase L. Beisel, Barbara Di Ventura
Institutions: Novo Nordisk Foundation, Loewe Center for Synthetic Microbiology, Max Planck Institute for Terrestrial Microbiology, Technical University of Denmark, University of Würzburg, Helmholtz Centre for Infection Research, Helmholtz Institute for RNA-based Infection Research, University of Freiburg
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $700
OpenAlex ID: W4205183002